A total of @ @ patients with AF and a raised risk of stroke were randomized to warfarin or apixaban @ mg b.d. with dose reduction to @ mg b.d. or placebo in @ patients with @ of the following criteria : age @ years , body weight @ kg , or creatinine @ mol/L .